107 related articles for article (PubMed ID: 4395696)
41. [A vertiginous syndrome due to sulfasalazine].
Sáez J; Gómez A; Santos G; García C; Griño P; Quílez C
Gastroenterol Hepatol; 1999 Apr; 22(4):207-8. PubMed ID: 10349796
[No Abstract] [Full Text] [Related]
42. CONTROLLED TRIAL OF SULPHASALAZINE IN THE TREATMENT OF ULCERATIVE COLITIS.
DICK AP; GRAYSON MJ; CARPENTER RG; PETRIE A
Gut; 1964 Oct; 5(5):437-42. PubMed ID: 14218553
[No Abstract] [Full Text] [Related]
43. Cholestasis in ulcerative colitis. Long term complications and medical therapy.
Cello JP
Gastroenterology; 1977 Aug; 73(2):372-4. PubMed ID: 873147
[No Abstract] [Full Text] [Related]
44. 5-Aminosalicylates, sulfasalazine, steroid use, and complications in patients with ulcerative colitis.
Walker AM; Szneke P; Bianchi LA; Field LG; Sutherland LR; Dreyer NA
Am J Gastroenterol; 1997 May; 92(5):816-20. PubMed ID: 9149192
[TBL] [Abstract][Full Text] [Related]
45. Salazopyrin-induced eosinophilic pneumonia.
Berliner S; Neeman A; Shoenfeld Y; Eldar M; Rousso I; Kadish U; Pinkhas J
Respiration; 1980; 39(2):119-20. PubMed ID: 6104854
[TBL] [Abstract][Full Text] [Related]
46. Bullous pemphigoid following use of sulphasalazine for ulcerative colitis: drug-induced eruption or true association?
Vaccaro M; D'Amico D; Borgia F; Guarneri F; Cannavò S
Dermatology; 2001; 203(2):194-5. PubMed ID: 11586028
[No Abstract] [Full Text] [Related]
47. [Individualized sulfasalazine treatment of ulcerative colitis and monitoring of patient compliance by determining sulfapyridine serum concentration].
Klugmann HJ; Giehler B; Lohmann D; Schiedewitz W
Gastroenterol J; 1990; 49(4):160-4. PubMed ID: 1970478
[TBL] [Abstract][Full Text] [Related]
48. Bullous eosinophilic cellulitis associated with ulcerative colitis: effective treatment with sulfasalazine and glucocorticoids.
Utikal J; Peitsch WK; Kemmler N; Booken N; Hildenbrand R; Gladisch R; Goerdt S; Goebeler M
Br J Dermatol; 2007 Apr; 156(4):764-6. PubMed ID: 17263808
[No Abstract] [Full Text] [Related]
49. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
Nakajima H; Munakata A; Yoshida Y
J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
[TBL] [Abstract][Full Text] [Related]
50. Folate, colitis, dysplasia, and cancer.
Mason JB
Nutr Rev; 1989 Oct; 47(10):314-7. PubMed ID: 2574841
[No Abstract] [Full Text] [Related]
51. Acute pericholangitis as the initial manifestation of fulminant ulcerative colitis.
Slavin S; Keynan A
Isr J Med Sci; 1972 Oct; 8(10):1716-20. PubMed ID: 4636298
[No Abstract] [Full Text] [Related]
52. [Pulmonary complications in patient with ulcerative colitis, treated with 5-aminosalicylic preparations].
Radwan P; łupina T; Radwan-Kwiatek K; Milanowski J
Pneumonol Alergol Pol; 2006; 74(2):224-6. PubMed ID: 17269374
[TBL] [Abstract][Full Text] [Related]
53. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study.
Pinczowski D; Ekbom A; Baron J; Yuen J; Adami HO
Gastroenterology; 1994 Jul; 107(1):117-20. PubMed ID: 7912678
[TBL] [Abstract][Full Text] [Related]
54. [Drug therapy of ulcerative colitis].
Rückert Y
Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):175-9. PubMed ID: 9244661
[TBL] [Abstract][Full Text] [Related]
55. [Ozone therapy combined with sulfasalazine delivered via a colon therapy system for treatment of ulcerative colitis].
Geng Y; Wang W; Ma Q; Peng LQ; Liang ZH
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Dec; 30(12):2683-5. PubMed ID: 21177179
[TBL] [Abstract][Full Text] [Related]
56. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.
Kam L; Cohen H; Dooley C; Rubin P; Orchard J
Am J Gastroenterol; 1996 Jul; 91(7):1338-42. PubMed ID: 8677990
[TBL] [Abstract][Full Text] [Related]
57. [Side effects of salicylazosulfapyridine therapy].
Miller B
Dtsch Med Wochenschr; 1980 Nov; 105(46):1596-7. PubMed ID: 6108200
[No Abstract] [Full Text] [Related]
58. [Ulcerative colitis with Coombs+ autoimmune hemolytic anemia. A report of a case with favorable response to medical treatment].
Suárez A; San Román FS; Rodríguez M; Riestra S; Navascués CA; Rodrigo L
Rev Esp Enferm Dig; 1994 Jun; 85(6):471-3. PubMed ID: 7915125
[TBL] [Abstract][Full Text] [Related]
59. Cholestasis associated with parenteral nutrition develops more commonly with hematologic malignancy than with inflammatory bowel disease.
Nanji AA; Anderson FH
JPEN J Parenter Enteral Nutr; 1984; 8(3):325. PubMed ID: 6429372
[No Abstract] [Full Text] [Related]
60. Relapse-preventing effect and safety of sulfasalazine and olsalazine in patients with ulcerative colitis in remission: a prospective, double-blind, randomized multicenter study. The Ulcerative Colitis Multicenter Study Group.
Rijk MC; van Lier HJ; van Tongeren JH
Am J Gastroenterol; 1992 Apr; 87(4):438-42. PubMed ID: 1348159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
